MARKET

ITRM

ITRM

Iterum Therapeutics Plc
NASDAQ
1.100
+0.020
+1.85%
After Hours: 1.099 -0.001 -0.05% 19:24 05/02 EDT
OPEN
1.090
PREV CLOSE
1.080
HIGH
1.110
LOW
1.065
VOLUME
331.18K
TURNOVER
--
52 WEEK HIGH
3.020
52 WEEK LOW
0.8080
MARKET CAP
39.26M
P/E (TTM)
-0.8747
1D
5D
1M
3M
1Y
5Y
1D
Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares
NASDAQ · 2d ago
Iterum Therapeutics prices 5.56M shares at 90c in registered direct offering
TipRanks · 3d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 3d ago
ITERUM THERAPEUTICS ANNOUNCES $5 MILLION REGISTERED DIRECT OFFERING OF ORDINARY SHARES
Reuters · 3d ago
Weekly Report: what happened at ITRM last week (0421-0425)?
Weekly Report · 4d ago
Weekly Report: what happened at ITRM last week (0414-0418)?
Weekly Report · 04/21 12:08
Iterum Therapeutics Announces That One Poster Was Presented On Impact Of Age On Antibiotic Resistance And Efficacy Of Antibiotics For Women With Uncomplicated Urinary Tract Infection At The 35th Annual European Congress of Clinical Microbiology and Infectious Disease In Vienna, Austria, From April 11-15, 2025.
Benzinga · 04/14 12:09
Weekly Report: what happened at ITRM last week (0407-0411)?
Weekly Report · 04/14 11:54
More
About ITRM
More
Iterum Therapeutics plc is a clinical-stage pharmaceutical company. The Company develops differentiated anti-infectives. It offers ORLYNVAH (sulopenem in an oral tablet formulation) medicine, which is an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women. Sulopenem is a potent, thiopenem antibiotic delivered intravenously which is active against bacteria that belong to the group of organisms known as gram-negatives and cause urinary tract and intra-abdominal infections. The Company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Recently
Symbol
Price
%Change

Webull offers Iterum Therapeutics PLC stock information, including NASDAQ: ITRM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ITRM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ITRM stock methods without spending real money on the virtual paper trading platform.